Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Antimetabolite dose intensity and adverse outcomes in children with acute lymphoblastic leukemia: a COG-AALL03N1 report

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anne Angiolillo, David S. Dickens, Joseph P. Neglia, Yaddanapudi Ravindranath, Amanda Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2024) 144 (22): 2327–2335.

https://doi.org/10.1182/blood.2024024455

Published: 2024

Includes: Supplemental data

Journal Articles

Clonal Hematopoiesis Is Associated with Non-Myeloid Subsequent Malignant Neoplasms after Autologous Hematopoietic Cell Transplantation

June-Wha Rhee, Sitong Chen, Raju Pillai, Alysia Bosworth, Artem Oganesyan, Liezl Atencio, Caitlyn Estrada, Mareen Kassabian, Lanie Lindenfeld, Scott R. Goldsmith, Michael Rosenzweig, Alex F. Herrera, Matthew Mei, Ryotaro Nakamura, F. Lennie Wong, Stephen J. Forman, Saro Armenian

Blood (2024) 144 (Supplement 1): 947.

https://doi.org/10.1182/blood-2024-200402

Published: 2024

Journal Articles

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Myeloid Malignancies: A BMTSS Report

Nora Balas, Joshua Richman, Wendy Landier, Sadeep Shrestha, Katia J Bruxvoort, Lindsey Hageman, Qingrui Meng, Elizabeth Ross, Alysia Bosworth, Hok Sreng Te, F. Lennie Wong, Ravi Bhatia, Stephen J. Forman, Saro Armenian, Daniel Weisdorf, Smita Bhatia

Blood (2024) 144 (Supplement 1): 403.

https://doi.org/10.1182/blood-2024-204551

Published: 2024

Journal Articles

Self-Rated Health Is an Independent Predictor of Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Plasma Cell Disorders: A BMTSS Report

Blood (2024) 144 (Supplement 1): 5146.

https://doi.org/10.1182/blood-2024-204623

Published: 2024

Journal Articles

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies - a BMT Survivor Study (BMTSS)

Blood (2024) 144 (Supplement 1): 5036.

https://doi.org/10.1182/blood-2024-204686

Published: 2024

Journal Articles

Long-Term Health Outcomes in Older (≥60 Years) Blood or Marrow Transplantation (BMT) Recipients: A Report from the Blood or Marrow Transplant Survivor Study (BMTSS)

Rusha Bhandari, Qingrui Meng, Nora Balas, Alysia Bosworth, F. Lennie Wong, Wendy Landier, Liton Francisco, Elizabeth Ross, Ravi Bhatia, Smita Bhatia, Saro Armenian, Lindsey Hageman

Blood (2024) 144 (Supplement 1): 2411.4.

https://doi.org/10.1182/blood-2024-199277

Published: 2024

Journal Articles

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Lymphoid Malignancies: A BMTSS Report

Blood (2024) 144 (Supplement 1): 2338.

https://doi.org/10.1182/blood-2024-204642

Published: 2024

Journal Articles

Social Vulnerability Is an Important Predictor of Cardiovascular Disease Risk after Allogeneic Hematopoietic Cell Transplantation

Osariemen Ogiamien, Sitong Chen, MHD Monzr M. Al Malki, Andrew Artz, Liezl Atencio, Alysia Bosworth, Meagan Echevarria, Caitlyn Estrada, Mareen Kassabian, Lanie Lindenfeld, Ryotaro Nakamura, June-Wha Rhee, F. Lennie Wong, Saro Armenian, Rusha Bhandari

Blood (2024) 144 (Supplement 1): 4924.

https://doi.org/10.1182/blood-2024-203678

Published: 2024

Journal Articles

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies - a BMT Survivor Study (BMTSS)

Blood (2024) 144 (Supplement 1): 5053.

https://doi.org/10.1182/blood-2024-204662

Published: 2024

Journal Articles

Disability Adjusted Life-Years (DALYs) As a Measure of the Changing Lifetime Disease Burden in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)

Sitong Chen, Alysia Bosworth, Liezl Atencio, MHD Monzr Al Malki, Stephen J. Forman, Ryotaro Nakamura, Saro Armenian, F. Lennie Wong

Blood (2023) 142 (Supplement 1): 238.

https://doi.org/10.1182/blood-2023-174107

Published: 2023

Journal Articles

Association between High Antimetabolite Dose Intensity during Maintenance, Toxicities and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): COG-AALL03N1 Report

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anne Angiolillo, David Dickens, Joseph Neglia, Yaddanapudi Ravindranath, Amanda Muench Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2023) 142 (Supplement 1): 521.

https://doi.org/10.1182/blood-2023-187197

Published: 2023

Journal Articles

Clonal Hematopoiesis Is Associated with Cardiovascular Disease Risk and Worse Survival after Autologous Hematopoietic Cell Transplantation for Lymphoma

Blood (2023) 142 (Supplement 1): 784.

https://doi.org/10.1182/blood-2023-177832

Published: 2023

Journal Articles

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Scott R. Goldsmith, Geoffrey P. Shouse, F. Lennie Wong, Alysia Bosworth, Aleksi Iujuridze, Sitong Chen, June-Wha Rhee, Matthew G. Mei, Murali Janakiram, Myo Htut, Stephen J. Forman, Raju Pillai, L. Elizabeth Budde, Saro Armenian

Blood (2023) 142 (Supplement 1): 4814.

https://doi.org/10.1182/blood-2023-185157

Published: 2023

Journal Articles

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

F. Lennie Wong, Scott R. Goldsmith, Kimlin Ashing, Amrita Krishnan, Michael Rosenzweig, Saro Armenian

Blood (2023) 142 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2023-174296

Published: 2023

Journal Articles

Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children’s Oncology Group study AALL03N1 report

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anna Hoppmann, Anne Angiolillo, David S. Dickens, Joseph P. Neglia, Yaddanapudi Ravindranath, A. Kim Ritchey, Amanda Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2023) 142 (3): 221–229.

https://doi.org/10.1182/blood.2023019631

Published: 2023

Includes: Supplemental data

Journal Articles

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Nickhill Bhakta, Kalatu Davies, PhD, Jesse Turner, PhD, Yichen Chen, PhD, Jaime Flerlage, MD MS, I-Chan Huang, PhD, Melissa M. Hudson, MD, John T. Lucas, Jr., MD MS, Monika Metzger, MD, Leslie L. Robison, PhD, F. Lennie Wong, PhD

Blood (2019) 134 (Supplement_1): 267.

https://doi.org/10.1182/blood-2019-124907

Published: 2019

Journal Articles

Self-Endorsed Cognitive Problems Vs. Objectively-Assessed Cognitive Impairment in Blood or Marrow Transplantation (BMT) Recipients — a Longitudinal Study

Donna Murdaugh, PhD, Alysia Bosworth, BA, Sunita Patel, PhD, Noha Sharafeldin, MBBCh, MSc, PhD, Yanjun Chen, MS, Liton F. Francisco, BS, Stephen J Forman, F. Lennie Wong, PhD, Smita Bhatia, MDMPH

Blood (2018) 132 (Supplement 1): 619.

https://doi.org/10.1182/blood-2018-99-110397

Published: 2018

Journal Articles

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Alex Iukuridze, Meisi Xiao, MPH, Lee Brandyn, Jennifer Berano Teh, Kristen Mascarenhas, Sandra Xu, Nicholas Rosen, Jeannine S McCune, PharmD, Jasmine M. Zain, MD, Robert W. Chen, MD, Leslie Popplewell, MD, Jessica Scott, PhD, Thomas Slavin, MD, Lee Jones, PhD, Stephen J Forman, Ryotaro Nakamura, MD, F. Lennie Wong, PhD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 620.

https://doi.org/10.1182/blood-2018-99-113689

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

DNA Repair Genes May Influence Cognitive Outcomes in Adult Patients with Hematologic Malignancies (HM) Treated with Blood or Marrow Transplantation (BMT)

Noha Sharafeldin, MBBCh, MSc, PhD, Alysia Bosworth, BA, Yanjun Chen, MS, Purnima Singh, PhD BS, MSc, Sunita Patel, PhD, Xuexia Wang, PhD, Emily Morse, MA, Molly Mather, MS, Can-Lan Sun, PhD, Liton F. Francisco, BS, Stephen J Forman, F. Lennie Wong, PhD, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 3411.

https://doi.org/10.1182/blood-2018-99-113043

Published: 2018

NARROW

Antimetabolite dose intensity and adverse outcomes in children with acute lymphoblastic leukemia: a COG-AALL03N1 report

Clonal Hematopoiesis Is Associated with Non-Myeloid Subsequent Malignant Neoplasms after Autologous Hematopoietic Cell Transplantation

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Myeloid Malignancies: A BMTSS Report

Self-Rated Health Is an Independent Predictor of Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Plasma Cell Disorders: A BMTSS Report

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies - a BMT Survivor Study (BMTSS)

Long-Term Health Outcomes in Older (≥60 Years) Blood or Marrow Transplantation (BMT) Recipients: A Report from the Blood or Marrow Transplant Survivor Study (BMTSS)

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Lymphoid Malignancies: A BMTSS Report

Social Vulnerability Is an Important Predictor of Cardiovascular Disease Risk after Allogeneic Hematopoietic Cell Transplantation

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies - a BMT Survivor Study (BMTSS)

Disability Adjusted Life-Years (DALYs) As a Measure of the Changing Lifetime Disease Burden in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)

Association between High Antimetabolite Dose Intensity during Maintenance, Toxicities and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): COG-AALL03N1 Report

Clonal Hematopoiesis Is Associated with Cardiovascular Disease Risk and Worse Survival after Autologous Hematopoietic Cell Transplantation for Lymphoma

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children’s Oncology Group study AALL03N1 report

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Self-Endorsed Cognitive Problems Vs. Objectively-Assessed Cognitive Impairment in Blood or Marrow Transplantation (BMT) Recipients — a Longitudinal Study

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

DNA Repair Genes May Influence Cognitive Outcomes in Adult Patients with Hematologic Malignancies (HM) Treated with Blood or Marrow Transplantation (BMT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only